levamisole has been researched along with ALS - Amyotrophic Lateral Sclerosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baugh, SD; Gregory-Evans, CY; Morrice, JR; Reitz, AB; Shaw, CA | 1 |
| Olarte, MR | 1 |
| Olarte, MR; Shafer, SQ | 2 |
| Lobzin, VS; Orlov, AB; Zvegintsova, TN | 1 |
3 trial(s) available for levamisole and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Therapeutic trials in amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levamisole; Male; Middle Aged | 1982 |
Methodological considerations for clinical trials in motor neuron disease.
Topics: Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Double-Blind Method; Humans; Levamisole; Motor Neurons; Neuromuscular Diseases; Random Allocation | 1982 |
Levamisole is ineffective in the treatment of amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Female; Humans; Levamisole; Male; Middle Aged; Placebos | 1985 |
2 other study(ies) available for levamisole and ALS - Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Levamisole derivatives as immune modulators for the treatment of amyotrophic lateral sclerosis (ALS).
Topics: Amyotrophic Lateral Sclerosis; Cytokines; Humans; Levamisole; Tetramisole | 2023 |
[Immunocorrective treatment of amyotrophic lateral sclerosis].
Topics: Adjuvants, Immunologic; Adult; Aged; Amyotrophic Lateral Sclerosis; Drug Therapy, Combination; Female; Humans; Leukocyte Count; Levamisole; Lymphopenia; Male; Middle Aged; Ribonucleases; T-Lymphocytes | 1991 |